Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115909) titled 'The influence of remimazolam besylate on vital signs and liver and kidney functions of patients undergoing laparoscopic surgery under general anesthesia' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Kaifeng 155 Hospital
Condition:
The impact of remimazolam besylate on maintaining anesthesia during general anesthesia for patients requiring laparoscopic surgery on their vital signs and liver and kidney functions.
Intervention:
Propofol group:Conventional induction, combined intravenous-inhalation with propofol and sevoflurane to maintain anesthesia
Recruitment Status: ...